Request for Nominations of Potential Reviewers To Serve on the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP), 2227-2228 [2019-01212]

Download as PDF Federal Register / Vol. 84, No. 25 / Wednesday, February 6, 2019 / Notices patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)–RFA–TS–19–001, Identify, Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS). Date: April 24, 2019. Time: 11:00 a.m.–5:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Kimberly Leeks, Ph.D., M.P.H., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone (770) 488–6562, KLeeks@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–01211 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention amozie on DSK3GDR082PROD with NOTICES1 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) PAR13–129; Amended Notice of Meeting Notice is hereby given of a change in the name of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) PAR13–129; February 26, 2019, 12:00 p.m.–4:00 p.m., EST which was published in the Federal Register on December 21, 2018 Volume 83, Number 245, page 65675. The meeting is being amended to change the funding opportunity announcement to PAR18–812. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Nina Turner, Ph.D., Scientific Review Officer, Office of Extramural Programs, 1095 Willowdale Road, Morgantown, West Virginia 26506, Telephone: (304) 285–5976; Email: nxt2@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to VerDate Sep<11>2014 18:09 Feb 05, 2019 Jkt 247001 2227 announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. Request for Nominations of Potential Reviewers To Serve on the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) [FR Doc. 2019–01206 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Notice of request for nominations. ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)–DD19–002, The Muscular Dystrophy Surveillance, Tracking, and Research Network(MD STARnet). Dates: April 2–3, 2019. Times: 10:00 a.m.–6:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop 80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, kva5@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–01210 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) in the National Center for Injury Prevention and Control (NCIPC), the National Center for Environmental Health (NCEH), and the Agency for Toxic Substances and Disease Registry (ATSDR). SUMMARY: Nominations for membership on the NCIPC, NCEH and ATSDR SEPs must be received no later than April 1, 2019. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to NCIPC Extramural Program Office (ERPO): Centers for Disease Control and Prevention, 4770 Buford Highway, Mailstop F–63, Atlanta, GA 30341, emailed (recommended) to NCIPC_PeerReview@cdc.gov, or faxed to (770) 488–4529. FOR FURTHER INFORMATION CONTACT: Kenneth Roberts, Public Health Analyst, CDC/NCIPC/ERPO, 4770 Buford Highway, Mailstop F–63, Atlanta, GA 30341; Telephone: (404) 498–1427; Email: KRoberts3@cdc.gov. SUPPLEMENTARY INFORMATION: The Disease, Disability, and Injury Prevention and Control Special Emphasis Panel provides advice and guidance to the Secretary, Department of Health and Human Services (HHS); the Director, Centers for Disease Control and Prevention (CDC), and the Administrator, Agency for Toxic Substances and Disease Registry (ATSDR) regarding the concept review, scientific and technical merit of grant and cooperative agreement assistance applications, and contract proposals relating to the causes, prevention, and control of diseases, disabilities, injuries, and impairments of public health significance; exposure to hazardous substances in the environment; health promotion and education; and other related activities that promote health and well-being. Nominations are being DATES: E:\FR\FM\06FEN1.SGM 06FEN1 amozie on DSK3GDR082PROD with NOTICES1 2228 Federal Register / Vol. 84, No. 25 / Wednesday, February 6, 2019 / Notices sought for individuals who have expertise and qualifications necessary to contribute to the accomplishment of NCIPC, NCEH and ATSDR SEP objectives. Reviewers with expertise in research for injury and violence prevention are sought to serve on the NCIPC SEPs, for research and evaluation related, but not limited to the following program fields: Child abuse and neglect, opioid use disorder and overdose, polysubstance use and impaired driving, suicide/self-directed violence, intimate partner violence, mechanisms of injury and violence research, motor vehicle injury, older adult falls, elder maltreatment, sexual violence, substance use and abuse, traumatic brain injury, teen dating violence, and youth violence related to NCIPC research priorities (see www.cdc.gov/ injury/researchpriorities). Reviewers with expertise in the following research fields for prevention and reduction of adverse effects related to environmental hazards are sought to serve on the NCEH and ATSDR SEPs for research and evaluation related, but not limited to: Amyotrophic Lateral Sclerosis (ALS), perfluoroalkyl substances (PFAS) contamination in drinking water, environmental health, newborn screening, environmental pollutants (air/water), toxic substances most commonly found at facilities on the National Priorities List (NPL) (see www.atsdr.cdc.gov/spl), chemical releases, natural disasters, and other potential NCEH or ATSDR research priorities. In addition, reviewers with expertise in the following general and methodological fields are sought to serve on the NCIPC, NCEH and ATSDR SEPs: Economic evaluation, epidemiology, etiology of disease, community participatory research, implementation and translation science, intervention research, policy evaluation, research evaluation, qualitative research design, quantitative research design, statistics, and surveillance. Members and Chairs shall be selected by the Secretary, HHS, or other official to whom the authority has been delegated, on an ‘‘as needed’’ basis in response to specific applications being reviewed with expertise to provide advice. Members will be selected from authorities in the various fields of prevention and control of diseases, disabilities, and injuries. Members of other chartered HHS advisory committees may serve on the panel if their expertise is required. Consideration is given to professional training and background, points of view represented, and upcoming applications to be reviewed by the committee. VerDate Sep<11>2014 18:09 Feb 05, 2019 Jkt 247001 Information about nominated potential reviewers will be maintained in the NCIPC Extramural Research Program Office (ERPO) Scientific Reviewer and Advisor Database. The work of reviewers’ appointed to NCIPC, NCEH and ATSDR SEPs includes the initial review, discussion, and written critique and evaluation of applications. This work will enable the CDC/NCIPC, NCEH and ATSDR to fulfill its mission of funding meritorious research that provides vital knowledge about underlying risk and protective factors and strategies for: Violence and injury prevention (www.cdc.gov/injury), health effects from exposures to environmental agents and hazardous substances (www.atsdr.cdc.gov), and the environmental public health impact caused by intentional or unintentional events (www.cdc.gov/nceh). The U.S. Department of Health and Human Services policy stipulates that committee membership be balanced in terms of points of view represented, and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. CDC reviewers appointed to a SEP are not considered Special Government Employees and will not be required to file financial disclosure reports. Nominees interested in serving as a potential reviewer on a SEP, CDC for NCIPC, NCEH, or ATSDR programs should submit the following items: • Current curriculum vitae, highlighting specific areas of research interest and expertise as well as complete contact information (name, affiliation, mailing address, telephone number, and email address). Nomination materials must be postmarked by April 1, 2019 and sent by U.S. mail to: NCIPC Extramural Research Program Office (ERPO): Centers for Disease Control and Prevention, 4770 Buford Highway, Mailstop F–63, Atlanta, Georgia 30341 or to the ERPO electronic mailbox NCIPC_PeerReview@cdc.gov. Nominations may be submitted by the candidate him- or herself, or by the person/organization recommending the candidate. PO 00000 Frm 00090 Fmt 4703 Sfmt 9990 The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–01212 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC); Notice of Charter Renewal Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of charter renewal. This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Healthcare Infection Control Practices Advisory Committee, Department of Health and Human Services, has been renewed for a 2-year period through January 19, 2021. SUMMARY: Erin Stone, M.A., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop A–07, Atlanta, Georgia 30329–4027, Telephone (404) 639–4045. Email; hicpac@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. FOR FURTHER INFORMATION CONTACT: Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–01207 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\06FEN1.SGM 06FEN1

Agencies

[Federal Register Volume 84, Number 25 (Wednesday, February 6, 2019)]
[Notices]
[Pages 2227-2228]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01212]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Request for Nominations of Potential Reviewers To Serve on the 
Disease, Disability, and Injury Prevention and Control Special Emphasis 
Panel (SEP)

ACTION: Notice of request for nominations.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
soliciting nominations for possible membership on the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP) in the National Center for Injury Prevention and Control (NCIPC), 
the National Center for Environmental Health (NCEH), and the Agency for 
Toxic Substances and Disease Registry (ATSDR).

DATES: Nominations for membership on the NCIPC, NCEH and ATSDR SEPs 
must be received no later than April 1, 2019. Packages received after 
this time will not be considered for the current membership cycle.

ADDRESSES: All nominations should be mailed to NCIPC Extramural Program 
Office (ERPO): Centers for Disease Control and Prevention, 4770 Buford 
Highway, Mailstop F-63, Atlanta, GA 30341, emailed (recommended) to 
NCIPC_PeerReview@cdc.gov, or faxed to (770) 488-4529.

FOR FURTHER INFORMATION CONTACT: Kenneth Roberts, Public Health 
Analyst, CDC/NCIPC/ERPO, 4770 Buford Highway, Mailstop F-63, Atlanta, 
GA 30341; Telephone: (404) 498-1427; Email: KRoberts3@cdc.gov.

SUPPLEMENTARY INFORMATION: The Disease, Disability, and Injury 
Prevention and Control Special Emphasis Panel provides advice and 
guidance to the Secretary, Department of Health and Human Services 
(HHS); the Director, Centers for Disease Control and Prevention (CDC), 
and the Administrator, Agency for Toxic Substances and Disease Registry 
(ATSDR) regarding the concept review, scientific and technical merit of 
grant and cooperative agreement assistance applications, and contract 
proposals relating to the causes, prevention, and control of diseases, 
disabilities, injuries, and impairments of public health significance; 
exposure to hazardous substances in the environment; health promotion 
and education; and other related activities that promote health and 
well-being. Nominations are being

[[Page 2228]]

sought for individuals who have expertise and qualifications necessary 
to contribute to the accomplishment of NCIPC, NCEH and ATSDR SEP 
objectives. Reviewers with expertise in research for injury and 
violence prevention are sought to serve on the NCIPC SEPs, for research 
and evaluation related, but not limited to the following program 
fields: Child abuse and neglect, opioid use disorder and overdose, 
polysubstance use and impaired driving, suicide/self-directed violence, 
intimate partner violence, mechanisms of injury and violence research, 
motor vehicle injury, older adult falls, elder maltreatment, sexual 
violence, substance use and abuse, traumatic brain injury, teen dating 
violence, and youth violence related to NCIPC research priorities (see 
www.cdc.gov/injury/researchpriorities). Reviewers with expertise in the 
following research fields for prevention and reduction of adverse 
effects related to environmental hazards are sought to serve on the 
NCEH and ATSDR SEPs for research and evaluation related, but not 
limited to: Amyotrophic Lateral Sclerosis (ALS), perfluoroalkyl 
substances (PFAS) contamination in drinking water, environmental 
health, newborn screening, environmental pollutants (air/water), toxic 
substances most commonly found at facilities on the National Priorities 
List (NPL) (see www.atsdr.cdc.gov/spl), chemical releases, natural 
disasters, and other potential NCEH or ATSDR research priorities. In 
addition, reviewers with expertise in the following general and 
methodological fields are sought to serve on the NCIPC, NCEH and ATSDR 
SEPs: Economic evaluation, epidemiology, etiology of disease, community 
participatory research, implementation and translation science, 
intervention research, policy evaluation, research evaluation, 
qualitative research design, quantitative research design, statistics, 
and surveillance.
    Members and Chairs shall be selected by the Secretary, HHS, or 
other official to whom the authority has been delegated, on an ``as 
needed'' basis in response to specific applications being reviewed with 
expertise to provide advice. Members will be selected from authorities 
in the various fields of prevention and control of diseases, 
disabilities, and injuries. Members of other chartered HHS advisory 
committees may serve on the panel if their expertise is required. 
Consideration is given to professional training and background, points 
of view represented, and upcoming applications to be reviewed by the 
committee.
    Information about nominated potential reviewers will be maintained 
in the NCIPC Extramural Research Program Office (ERPO) Scientific 
Reviewer and Advisor Database. The work of reviewers' appointed to 
NCIPC, NCEH and ATSDR SEPs includes the initial review, discussion, and 
written critique and evaluation of applications. This work will enable 
the CDC/NCIPC, NCEH and ATSDR to fulfill its mission of funding 
meritorious research that provides vital knowledge about underlying 
risk and protective factors and strategies for: Violence and injury 
prevention (www.cdc.gov/injury), health effects from exposures to 
environmental agents and hazardous substances (www.atsdr.cdc.gov), and 
the environmental public health impact caused by intentional or 
unintentional events (www.cdc.gov/nceh).
    The U.S. Department of Health and Human Services policy stipulates 
that committee membership be balanced in terms of points of view 
represented, and the committee's function. Appointments shall be made 
without discrimination on the basis of age, race, ethnicity, gender, 
sexual orientation, gender identity, HIV status, disability, and 
cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens, and cannot be full-time employees of the U.S. Government. 
Current participation on federal workgroups or prior experience serving 
on a federal advisory committee does not disqualify a candidate; 
however, HHS policy is to avoid excessive individual service on 
advisory committees and multiple committee memberships. CDC reviewers 
appointed to a SEP are not considered Special Government Employees and 
will not be required to file financial disclosure reports.
    Nominees interested in serving as a potential reviewer on a SEP, 
CDC for NCIPC, NCEH, or ATSDR programs should submit the following 
items:
     Current curriculum vitae, highlighting specific areas of 
research interest and expertise as well as complete contact information 
(name, affiliation, mailing address, telephone number, and email 
address).
    Nomination materials must be postmarked by April 1, 2019 and sent 
by U.S. mail to: NCIPC Extramural Research Program Office (ERPO): 
Centers for Disease Control and Prevention, 4770 Buford Highway, 
Mailstop F-63, Atlanta, Georgia 30341 or to the ERPO electronic mailbox 
NCIPC_PeerReview@cdc.gov. Nominations may be submitted by the candidate 
him- or herself, or by the person/organization recommending the 
candidate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities for both CDC and the Agency for Toxic Substances 
and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-01212 Filed 2-5-19; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.